Cargando…

A Ferroptosis-Related LncRNA Signature Associated with Prognosis, Tumor Immune Environment, and Genome Instability in Hepatocellular Carcinoma

BACKGROUND: Ferroptosis is an iron-dependent form of cell death. In this study, we identified ferroptosis-related long noncoding RNAs (FRlncRNAs) to investigate their association with hepatocellular carcinoma (HCC) in prognosis, tumor immune environment, and genome instability. METHODS: Transcriptom...

Descripción completa

Detalles Bibliográficos
Autores principales: Lian, Jie, Zhang, Chaoyu, Lu, Haibo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9410853/
https://www.ncbi.nlm.nih.gov/pubmed/36035299
http://dx.doi.org/10.1155/2022/6284540
_version_ 1784775187677315072
author Lian, Jie
Zhang, Chaoyu
Lu, Haibo
author_facet Lian, Jie
Zhang, Chaoyu
Lu, Haibo
author_sort Lian, Jie
collection PubMed
description BACKGROUND: Ferroptosis is an iron-dependent form of cell death. In this study, we identified ferroptosis-related long noncoding RNAs (FRlncRNAs) to investigate their association with hepatocellular carcinoma (HCC) in prognosis, tumor immune environment, and genome instability. METHODS: Transcriptome profile data of HCC were retrieved from a public database. FRlncRNAs were identified by co-expression analysis. Patients were randomly divided into training and test cohorts. Univariate Cox analysis and Least Absolute Shrinkage and Selection Operator (LASSO) Cox regression were performed to construct a risk model. Patients were divided into high- and low-risk groups based on the risk model. AUC and C index were used to assess the risk model. Survival analysis, immune status, and genome instability were compared between the two groups. RESULTS: Sixteen FRlncRNAs were identified and used to construct an FRlncRNA signature for the risk model. The Kaplan-Meier analysis revealed that patients in the high-risk group had poorer overall survival than patients in the low-risk group. The area under curve of the risk model was 0.879, 0.809, and 0.757 in the training cohort and 0.635, 0.688, and 0.739 in the test cohort at 1, 2, and 3 years, respectively. The risk model was an independent prognostic predictor and showed excellent prediction of prognosis compared with clinicopathological features. For the differentially expressed ferroptosis-related genes, many enriched metabolic pathways were identified in the functional enrichment analysis. Immune cells such as CD8+ T cells, macrophages M1, natural killer cells, and B cells, which may be associated with antitumor immune responses, differed between the high- and low-risk groups. Genome instability based on the risk model was also explored. A total of 61 genes were differently mutated between the two risk groups, and among them, TP53, HECW2, TRIM66, MCTP2, and KIAA1551 had the most significant mutation frequency differences. CONCLUSION: The FRlncRNA signature is closely related with overall survival, tumor immune environment, and genome instability in HCC.
format Online
Article
Text
id pubmed-9410853
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Hindawi
record_format MEDLINE/PubMed
spelling pubmed-94108532022-08-26 A Ferroptosis-Related LncRNA Signature Associated with Prognosis, Tumor Immune Environment, and Genome Instability in Hepatocellular Carcinoma Lian, Jie Zhang, Chaoyu Lu, Haibo Comput Math Methods Med Research Article BACKGROUND: Ferroptosis is an iron-dependent form of cell death. In this study, we identified ferroptosis-related long noncoding RNAs (FRlncRNAs) to investigate their association with hepatocellular carcinoma (HCC) in prognosis, tumor immune environment, and genome instability. METHODS: Transcriptome profile data of HCC were retrieved from a public database. FRlncRNAs were identified by co-expression analysis. Patients were randomly divided into training and test cohorts. Univariate Cox analysis and Least Absolute Shrinkage and Selection Operator (LASSO) Cox regression were performed to construct a risk model. Patients were divided into high- and low-risk groups based on the risk model. AUC and C index were used to assess the risk model. Survival analysis, immune status, and genome instability were compared between the two groups. RESULTS: Sixteen FRlncRNAs were identified and used to construct an FRlncRNA signature for the risk model. The Kaplan-Meier analysis revealed that patients in the high-risk group had poorer overall survival than patients in the low-risk group. The area under curve of the risk model was 0.879, 0.809, and 0.757 in the training cohort and 0.635, 0.688, and 0.739 in the test cohort at 1, 2, and 3 years, respectively. The risk model was an independent prognostic predictor and showed excellent prediction of prognosis compared with clinicopathological features. For the differentially expressed ferroptosis-related genes, many enriched metabolic pathways were identified in the functional enrichment analysis. Immune cells such as CD8+ T cells, macrophages M1, natural killer cells, and B cells, which may be associated with antitumor immune responses, differed between the high- and low-risk groups. Genome instability based on the risk model was also explored. A total of 61 genes were differently mutated between the two risk groups, and among them, TP53, HECW2, TRIM66, MCTP2, and KIAA1551 had the most significant mutation frequency differences. CONCLUSION: The FRlncRNA signature is closely related with overall survival, tumor immune environment, and genome instability in HCC. Hindawi 2022-08-18 /pmc/articles/PMC9410853/ /pubmed/36035299 http://dx.doi.org/10.1155/2022/6284540 Text en Copyright © 2022 Jie Lian et al. https://creativecommons.org/licenses/by/4.0/This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Research Article
Lian, Jie
Zhang, Chaoyu
Lu, Haibo
A Ferroptosis-Related LncRNA Signature Associated with Prognosis, Tumor Immune Environment, and Genome Instability in Hepatocellular Carcinoma
title A Ferroptosis-Related LncRNA Signature Associated with Prognosis, Tumor Immune Environment, and Genome Instability in Hepatocellular Carcinoma
title_full A Ferroptosis-Related LncRNA Signature Associated with Prognosis, Tumor Immune Environment, and Genome Instability in Hepatocellular Carcinoma
title_fullStr A Ferroptosis-Related LncRNA Signature Associated with Prognosis, Tumor Immune Environment, and Genome Instability in Hepatocellular Carcinoma
title_full_unstemmed A Ferroptosis-Related LncRNA Signature Associated with Prognosis, Tumor Immune Environment, and Genome Instability in Hepatocellular Carcinoma
title_short A Ferroptosis-Related LncRNA Signature Associated with Prognosis, Tumor Immune Environment, and Genome Instability in Hepatocellular Carcinoma
title_sort ferroptosis-related lncrna signature associated with prognosis, tumor immune environment, and genome instability in hepatocellular carcinoma
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9410853/
https://www.ncbi.nlm.nih.gov/pubmed/36035299
http://dx.doi.org/10.1155/2022/6284540
work_keys_str_mv AT lianjie aferroptosisrelatedlncrnasignatureassociatedwithprognosistumorimmuneenvironmentandgenomeinstabilityinhepatocellularcarcinoma
AT zhangchaoyu aferroptosisrelatedlncrnasignatureassociatedwithprognosistumorimmuneenvironmentandgenomeinstabilityinhepatocellularcarcinoma
AT luhaibo aferroptosisrelatedlncrnasignatureassociatedwithprognosistumorimmuneenvironmentandgenomeinstabilityinhepatocellularcarcinoma
AT lianjie ferroptosisrelatedlncrnasignatureassociatedwithprognosistumorimmuneenvironmentandgenomeinstabilityinhepatocellularcarcinoma
AT zhangchaoyu ferroptosisrelatedlncrnasignatureassociatedwithprognosistumorimmuneenvironmentandgenomeinstabilityinhepatocellularcarcinoma
AT luhaibo ferroptosisrelatedlncrnasignatureassociatedwithprognosistumorimmuneenvironmentandgenomeinstabilityinhepatocellularcarcinoma